Xanthine oxidoreductase-IN-5

Xanthine oxidoreductase-IN-5 is an orally active xanthine oxidoreductase (XOR) inhibitor, with an IC50 of 55 nM. Xanthine oxidoreductase-IN-5 can be used for the research of acute hyperuricemia[1].

Product Specifications

CAS Number

[1026652-90-3]

UNSPSC

12352005

Target

Xanthine Oxidase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/xanthine-oxidoreductase-in-5.html

Purity

98.93

Solubility

DMSO : 5 mg/mL (ultrasonic)

Smiles

CC(OC1=CC=C(C=C1)NC(C2=CC=C(C=C2)C3=NN=NN3)=O)C

Molecular Formula

C17H17N5O2

Molecular Weight

323.35

References & Citations

[1]Peng W, et, al. Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors. Eur J Med Chem. 2022 Nov 28;246:114947.